These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 38282150)

  • 1. Prognosis and therapy in thyroid cancer by gene signatures related to natural killer cells.
    Jin Z; Han Y; Zhang J; Liu Z; Li R; Liu Z
    J Gene Med; 2024 Jan; 26(1):e3657. PubMed ID: 38282150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of disulfidptosis-associated genes and characterization of immune cell infiltration in thyroid carcinoma.
    Song S; Zhou J; Zhang L; Sun Y; Zhang Q; Tan Y; Zhou X; Yu J
    Aging (Albany NY); 2024 Jun; 16(11):9753-9783. PubMed ID: 38836761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and validation of a novel senescence-related biomarker for thyroid cancer to predict the prognosis and immunotherapy.
    Hong K; Cen K; Chen Q; Dai Y; Mai Y; Guo Y
    Front Immunol; 2023; 14():1128390. PubMed ID: 36761753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
    Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
    BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model.
    Tan Z; Chen X; Zuo J; Fu S; Wang H; Wang J
    J Transl Med; 2023 Mar; 21(1):223. PubMed ID: 36973787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation a prognostic model based on natural killer T cells marker genes for predicting prognosis and characterizing immune status in glioblastoma through integrated analysis of single-cell and bulk RNA sequencing.
    Hu J; Xu L; Fu W; Sun Y; Wang N; Zhang J; Yang C; Zhang X; Zhou Y; Wang R; Zhang H; Mou R; Du X; Li X; Hu S; Xie R
    Funct Integr Genomics; 2023 Aug; 23(3):286. PubMed ID: 37650991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of a ferroptosis-related five-lncRNA signature for predicting prognosis and immune response in thyroid carcinoma.
    Qin Y; Zhang D; Zhang H; Hou L; Wang Z; Yang L; Zhang M; Zhao G; Yao Q; Ling R; Zhang J
    Cancer Cell Int; 2022 Sep; 22(1):296. PubMed ID: 36175889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of an ovarian cancer omentum metastasis-related prognostic model by integrated analysis of scRNA-seq and bulk RNA-seq.
    Zhang D; Lu W; Cui S; Mei H; Wu X; Zhuo Z
    J Ovarian Res; 2022 Nov; 15(1):123. PubMed ID: 36424614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen-related genes for thyroid cancer prognosis, immune infiltration, staging, and drug sensitivity.
    Zhang L; Zhou M; Gao X; Xie Y; Xiao J; Liu T; Zeng X
    BMC Cancer; 2023 Oct; 23(1):1048. PubMed ID: 37907864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Validation of Potential Molecular Subtypes and Signatures of Thyroid Carcinoma Based on Aging-related Gene Analysis.
    Li Z; Jia LI; Zhou HR; Zhang LU; Zhang M; Lv J; Deng ZY; Liu C
    Cancer Genomics Proteomics; 2024; 21(1):102-117. PubMed ID: 38151291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of Prognosis and Immunotherapy Response with a Novel Natural Killer Cell Marker Genes Signature in Osteosarcoma.
    Li Q; Huang X; Zhao Y
    Cancer Biother Radiopharm; 2024 Sep; 39(7):502-516. PubMed ID: 37889617
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer cell-related prognostic risk model predicts prognosis and treatment outcomes in triple-negative breast cancer.
    Liu Z; Ding M; Qiu P; Pan K; Guo Q
    Front Immunol; 2023; 14():1200282. PubMed ID: 37520534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and Validation of NK Marker Genes in Ovarian Cancer by scRNA-seq Combined with WGCNA Algorithm.
    He X; Feng W
    Mediators Inflamm; 2023; 2023():6845701. PubMed ID: 37144238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The fatty acid-related gene signature stratifies poor prognosis patients and characterizes TIME in cutaneous melanoma.
    Hua S; Wang W; Yao Z; Gu J; Zhang H; Zhu J; Xie Z; Jiang H
    J Cancer Res Clin Oncol; 2024 Jan; 150(2):40. PubMed ID: 38279987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mining Prognostic Biomarkers of Thyroid Cancer Patients Based on the Immune-Related Genes and Development of a Reliable Prognostic Risk Model.
    Fei H; Han X; Wang Y; Li S
    Mediators Inflamm; 2023; 2023():6503476. PubMed ID: 37554551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification a unique disulfidptosis classification regarding prognosis and immune landscapes in thyroid carcinoma and providing therapeutic strategies.
    Feng Z; Zhao Q; Ding Y; Xu Y; Sun X; Chen Q; Zhang Y; Miao J; Zhu J
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11157-11170. PubMed ID: 37347261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated analysis of single-cell and bulk RNA-sequencing reveals a novel signature based on NK cell marker genes to predict prognosis and immunotherapy response in gastric cancer.
    Sun JR; Kong CF; Ye YX; Wang Q; Qu XK; Jia LQ; Wu S
    Sci Rep; 2024 Apr; 14(1):7648. PubMed ID: 38561388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-Cell RNA Sequencing Revealed a 3-Gene Panel Predicted the Diagnosis and Prognosis of Thyroid Papillary Carcinoma and Associated With Tumor Immune Microenvironment.
    Chen Z; Wang Y; Li D; Le Y; Han Y; Jia L; Yan C; Tian Z; Song W; Li F; Zhao K; He X
    Front Oncol; 2022; 12():862313. PubMed ID: 35359404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TTN mutations predict a poor prognosis in patients with thyroid cancer.
    Han X; Chen J; Wang J; Xu J; Liu Y
    Biosci Rep; 2022 Jul; 42(7):. PubMed ID: 35766333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.